More on CSTL
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $24.69 |
|
|||
| Open | $25.10 | ||||
| 52 Wk High | $3.92 | ||||
| 52 Wk Low | $0.00 | ||||
| Day High | $25.12 | ||||
| Day Low | $23.85 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 291,638 | ||||
- Castle Biosciences to Present at the Canaccord Genuity 46th Annual Growth Conference
- Form 4 CASTLE BIOSCIENCES INC For: Jul 14 Filed by: MAETZOLD DEREK J
- Castle Biosciences wins New York approval for atopic dermatitis test
- Castle Biosciences Announces New York State Department of Health Approval of its AdvanceAD-Tx™ Test
- Castle Biosciences (CSTL) PT Lowered to $36 at Baird
- Castle Biosciences to Release Second Quarter 2026 Financial Results and Host Webcast on Thursday, July 30, 2026
- Form 4 CASTLE BIOSCIENCES INC For: Jul 01 Filed by: MAETZOLD DEREK J
- Form 4 CASTLE BIOSCIENCES INC For: Jul 01 Filed by: Oelschlager Kristen M
- Form 144 CASTLE BIOSCIENCES INC Filed by: MAETZOLD DEREK J
- Castle Biosciences melanoma test outperforms MIA nomogram in study
Entities mentioned with CSTL
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Canaccord Genuity | View Related Stories »
- S1 | View Related Stories »
- Show More...
